PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35368946-0	2022	Clinical Efficacy of Yiqi Yangyin Decoction Combined with Docetaxel on Advanced Ovarian Cancer and the Effect on the Levels of Serum Markers VEGF, HE4, and CA125.	Docetaxel	58-67	WAP four-disulfide core domain 2	Homo sapiens	147-150	
35368946-1	2022	Objective: The study is designed to investigate the therapeutic effect of Yiqi Yangyin Decoction combined with docetaxel on advanced ovarian cancer (OC) patients and the effects on serum markers VEGF, HE4, and CA125.	Docetaxel	111-120	WAP four-disulfide core domain 2	Homo sapiens	201-204